Pag-aaral pangklinika para sa COPD sa Florida
28 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
- Miami18 pag-aaral
- Orlando15 pag-aaral
- Hialeah8 pag-aaral
- Kendall7 pag-aaral
- Tampa7 pag-aaral
- West Palm Beach6 pag-aaral
- Jacksonville5 pag-aaral
- Ocala5 pag-aaral
- Boca Raton4 pag-aaral
- Doral4 pag-aaral
- Deltona3 pag-aaral
- St. Petersburg3 pag-aaral
- Plantation3 pag-aaral
- Cape Coral3 pag-aaral
- Clearwater3 pag-aaral
- Naples3 pag-aaral
- Palm Coast3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07780656A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Nagre-recruitPhase 4
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- at 10 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- Direct Helpers Research Center- Site Number : 8400057, Hialeah
- Pulmonary Specialists of the Palm Beaches- Site Number : 8400017, Loxahatchee Groves
- at 10 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07190222A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- at 17 pa
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- at 5 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- at 9 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- at 9 pa
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07705737A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- at 25 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06283966Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- at 2 pa
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07684820STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- at 8 pa
Nagre-recruitPhase 3
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
Nagre-recruit
Edad 40 hanggang 84 · Lahat ng kasarian · Na-update Abr 24, 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- at 15 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- at 2 pa
Nagre-recruit
Edad 30 pataas · Lahat ng kasarian · Na-update Peb 6, 2025 · NCT05204888Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.